Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 6Colorectal Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Kaposi 2Rectal Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lung Neoplasms 2Inflammatory Bowel Diseases 2Head and Neck Neoplasms 2HIV Infections 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Renal Insufficiency 1Recurrence 1Radiation Injuries 1Prostatic Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1

Interventions

Hydralazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × OTHER_GOV × Locally Advanced Breast Cancer × Clear all
NCT00395655 2006-11-03

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

National Institute of Cancerología

Phase 2 Terminated
43 enrolled
Breast

Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡